Source: ShaMaran Petroleum.

ShaMaran Petroleum Corp. (SNM) has announced an Atrush operations update.

Drilling operations have commenced on the CK-18 production well in the Atrush Block in the Kurdistan Region of Iraq.

This well will be a Lower Jurassic deviated production well drilled to the southwest from the Chamanke G Pad and located to the north of wells CK-15 and CK-8.

CK-18 is forecast to produce up to 2,000 barrels of oil per day.

Workover operations have also commenced on CK-17 ST-1 production well in the Atrush Block in the Kurdistan Region of Iraq.

CK-17 ST-1 is a side-tracked deviated well drilled from the Chamanke ‘A’ Pad and penetrating the Upper Jurassic between the CK-5 and CK-8 wells. The main objectives of this workover will be to re-complete the well in the Upper Jurassic and to add perforations for stimulation to increase forecasted production up to 5,000 barrels of fluids per day.

Also, drilling operations have recently concluded on CK-16, a water disposal well, drilled from the Chamanke G Pad and designed to provide redundancy to the existing Atrush water disposal well, CK-9.

Dr. Adel Chaouch, President and Chief Executive Officer of ShaMaran commented,

“These drilling campaigns are consistent with the joint venture’s plans to establish a new production plateau for the Atrush Field.”

ShaMaran Petroleum Corp’s (SNM) share price remains unchanged as of end-of-day trading at C$0.075 as of 4 pm EDT.


More From The Market Online
The Market Online Video

Prospera Energy plots success with proven reserves, M&A plans

Prospera Energy (TSXV:PEI) CEO Samuel David discusses the company's latest news and the forecast for 2024 in an exclusive interview.

Parkland pays City of Burnaby $31K for emergency response

Parkland Corp. (TSX:PKI) cut a cheque to the City of Burnaby, B.C., to cover costs after an incident at its plant earlier this year.

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

Stockhouse Bullboards users have been tracking a trajectory among Bombardier, Baytex and Tilray that they hope will share comparable results.